ClinVar Miner

Submissions for variant NM_000132.3(F8):c.1804C>T (p.Arg602Ter) (rs137852424)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
NIHR Bioresource Rare Diseases, University of Cambridge RCV000852054 SCV000899563 pathogenic Hereditary factor IX deficiency disease 2019-02-01 criteria provided, single submitter research
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000010945 SCV001160019 pathogenic Hereditary factor VIII deficiency disease 2018-10-05 criteria provided, single submitter clinical testing The F8 c.1804C>T; p.Arg602Ter variant (rs137852424), also known as R583X, is reported in the literature in multiple individuals affected with moderate to severe hemophilia A (Johnsen 2017, Lu 2018, Salviato 2007, F8 database and references therein). This variant is reported in ClinVar (Variation ID: 10232), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Functional analyses of the variant protein show a lack of immunofluorescence staining, suggesting degradation of the truncated RNA occurs (Zimmermann 2014). Based on available information, the p.Arg602Ter variant is considered to be pathogenic. References: Link to F8 database: Johnsen JM et al. Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative. Blood Adv. 2017 May 18;1(13):824-834. Lu Y et al. Spectrum and origin of mutations in sporadic cases of haemophilia A in China. Haemophilia. 2018 Mar;24(2):291-298. Salviato R et al. F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors. Haemophilia. 2007 Jul;13(4):361-72. Zimmermann MA et al. Expression studies of mutant factor VIII alleles with premature termination codons with regard to inhibitor formation. Haemophilia. 2014 May;20(3):e215-21.
OMIM RCV000010945 SCV000031172 pathogenic Hereditary factor VIII deficiency disease 1995-01-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.